Pacific Biosciences Of California (PACB) Operating Expenses (2010 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly Operating Expenses of $21.2 million for Q1 2026, down 95.04% year-over-year from $427.6 million in Q1 2025, and down 63.3% quarter-over-quarter from $57.8 million in Q4 2025.
Pacific Biosciences Of California (PACB) Operating Expenses (2010 - 2026) Analysis & Trends
Pacific Biosciences Of California's Operating Expenses history runs 17 years deep, the most recent figure standing at $21.2 million for Q1 2026.
- In Q1 2026, Operating Expenses fell 95.04% year-over-year to $21.2 million; the TTM figure through Mar 2026 stood at $193.3 million (down 77.17% YoY), while the FY2025 annual figure was $599.6 million, up 17.21% from the prior year.
- Operating Expenses for Q1 2026 stood at $21.2 million, down from $57.8 million in the prior quarter.
- The five-year high for Operating Expenses was $427.6 million in Q1 2025, with the low at $21.2 million in Q1 2026.
- The 5-year median for Operating Expenses is $91.7 million (2022), against an average of $110.3 million.
- The sharpest annual moves came in 2022 and 2026: Operating Expenses soared 634.72% in 2022, then sank 95.04% in 2026.
- Pacific Biosciences Of California's Operating Expenses stood at $92.2 million in 2022, then gained by 5.31% to $97.1 million in 2023, then soared by 67.92% to $163.1 million in 2024, then slumped by 64.58% to $57.8 million in 2025, then plunged by 63.3% to $21.2 million in 2026.
- Business Quant data shows PACB's Operating Expenses at $21.2 million in Q1 2026, $57.8 million in Q4 2025, and $54.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 10.90 Bn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 2.84 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 3.59 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 2.67 Bn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 846.40 Mn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 511.70 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 1.44 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | -741.59 Mn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 398.30 Mn |
| 10 | Pacific Biosciences Of California | 397.64 Mn | 160.77 Mn | 12.64 Mn | 57.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 57.25 Mn |
| Mar 31, 2026 | 21.20 Mn |
| Dec 31, 2025 | 57.76 Mn |
| Sep 30, 2025 | 54.78 Mn |
| Jun 30, 2025 | 59.54 Mn |
| Mar 31, 2025 | 427.56 Mn |
| Dec 31, 2024 | 163.09 Mn |
| Sep 30, 2024 | 74.08 Mn |
| Jun 30, 2024 | 181.78 Mn |
| Mar 31, 2024 | 92.64 Mn |
| Dec 31, 2023 | 97.12 Mn |
| Sep 30, 2023 | 100.39 Mn |
| Jun 30, 2023 | 88.72 Mn |
| Mar 31, 2023 | 101.01 Mn |
| Dec 31, 2022 | 92.22 Mn |
| Sep 30, 2022 | 88.17 Mn |
| Jun 30, 2022 | 84.16 Mn |
| Mar 31, 2022 | 91.68 Mn |
| Dec 31, 2021 | 81.44 Mn |
| Sep 20, 2021 | 12.00 Mn |